INTRODUCTION
Diclofenac and paracetamol (acetaminophen) are either pain relievers, or analgesics, and can reduce fevers. They differ in numerous ways, however, such as in their drug classification and strength. Consumers will find other differences between these drugs in their ease of access to them, and the types of side effects or warnings that accompany them. Moreover, one or the other of these medications may be a better choice for treating certain illnesses.
Paracetamol is considered to be a mild analgesic and antipyretic, or fever reducer. Diclofenac also has painrelieving and fever-reducing properties, but it belongs to a special class of drugs called non-steroidal antiinflammatory drugs (NSAIDs). This class of medicines tends to be more useful in controlling swelling from injury. Such anti-inflammatory properties are not characteristic of paracetamol.
Undoubtedly, diclofenac is considered a stronger drug than paracetamol, though strength depends at least in part on dosage. The relative strengths of diclofenac and paracetamol affect access to these medications. Paracetamol is widely available by itself or in combination forms for purchase by the general public. The drug is also combined with opioids in prescription pain relievers. In most countries, diclofenac isn't sold to consumers without a prescription and it is usually not combined with other medicines.
Another distinction between diclofenac and paracetamol is that they're likely to be recommended for different uses. Typically acetaminophen treats mild fevers or pain, and it might especially be recommended for people who cannot take NSAIDS due to allergy or stomach sensitivity. In contrast, conditions that might warrant treatment with diclofenac include arthritis, injuries to the muscles, dental surgery, gall bladder dysfunction, and kidney or bladder stones.
Also, differing side effects may accompany the use of diclofenac and paracetamol. Diclofenac may cause mild to major stomach upset, is more likely to result in allergy, and can seriously irritate the stomach lining and result in ulcers over time. The biggest concern with acetaminophen is that overdose or persistent use of the drug with alcohol may result in irreparable liver damage.
Some other variations between diclofenac and paracetamol are worth mentioning. Paracetamol is more likely to be employed for minor, "first-aid" conditions and would probably be more commonly used to treat fevers. It's also often much less expensive than diclofenac. Both drugs come with warnings about appropriate use, but in the case of diclofenac, physician guidance is also given during use because it is prescribed. Neither drug is "better" than the other, but advice from a physician may guide people toward the best choice for a specific medical condition.
World Health Organization (WHO) has suggested a pain management protocol which states that simple analgesics should be selected first and in case the patient does not respond to that, one can choose any other nonsteroidal anti-inflammatory drug (NSAID) and thereafter give a combination of NSAID with opioid analgesic. There is no place for fixed dose combination (FDC) of two NSAIDs in it. Currently FDC of diclofenac with paracetamol are available in Indian market and are widely used for pain relief. 1, 2 A combination of analgesics from different classes may provide additive analgesic effects with fewer side effects than when a single therapeutic drug is used. There has been a trend over recent years for combining Diclofenac with paracetamol for the management of various conditions i.e. due to analgesic, anti-inflammatory and anti-pyretic effect. However the results of previous study remained controversial. 3, 4 The main reasons for developing combination analgesics are to gain efficacy and to reduce toxicity. 5, 6 The combination of non-steroidal anti-inflammatory drugs is widely used in practice. There is no good clinical and experimental data to suggest combination is beneficial.
This experimental study was done to evaluate and compare the effects of diclofenac and paracetamol and its combination on analgesic, anti-inflammatory and antipyretic efficacy.
METHODS
The study was carried out after obtaining approval from Institutional Animal Ethics Committee. Albino mice of either sex weighing 20-25gm and wistar rats weighing 100-150gm were used.
The animals were housed in standard metal cages, 12 hour light/dark cycle and provided with food and water ad-libitum. The animals were fasted overnight before experiments but there was free access to drinking water. We used appropriate number of animals in each group for each different test method. In each test we used test and control groups. Diclofenac sodium (1mg/kg and 2mg/kg), paracetamol (10mg/kg and 20mg/kg) and their combination were administered in the ratio of 1:10 by oral feeding tube. The doses were calculated on the basis of mg/kg weight of the respective of each animal. Since drugs we used were insoluble in water a suspension was prepared in 1% tragacanth. The control group received 0.5 ml of 1% tragacanth suspension orally. Different methods used to evaluate analgesic, anti-inflammatory and anti-pyretic efficacy are shown in Table 1 For anti-inflammatory activity carrageenan induced rat paw method of Winter et al (1962) 9 was used.
For anti-pyretic activity we used TAB vaccine induced pyrexia, method of Dange et al (1985) . 10 In our study we used the same species used by the inventor of the different method
Statistical Analyses
All results were recorded as mean±SEM of the duration of analgesia, anti-inflammatory and antipyretic effect. Unpaired 't' test was used to find the significance of difference in the means of control and experimental group. P value less than 0.05 was considered statistically significant. We calculated the sample size as a function of effect size D a for a two-sample t-test comparison assuming a significance level of 5%, a power of 90%, and a two-sided test.
RESULTS
Analgesic efficacy was compared using tail-clip method between the three groups. Duration of analgesia is shown in Table 2 . Percentage decrease in number of wriths is shown in Figure 1 . Percentage protection by acetic acid induced writhing is shown in Table 3 . Comparison of anti-inflammatory efficacy between the three drug groups using rat paw edema is seen in Table 4 . Effect of drug on rat paw edema at 1 hr and 3 hr is shown in Figure 2 and Figure 3 respectively.
Comparison of efficacy of drug groups on Tab vaccine induced pyrexia is shown in Table 5 and Figure 4 .
DISCUSSION
The fixed dose combination of diclofenac and paracetamol (50mg and 500mg respectively) is extensively prescribed medicament for a variety of musculoskeletal disorders in India. This combination appears to be promoted exclusively in India. 12 Various experimental and clinical studies have been carried out on fixed dose drug combination of ibuprofen and paracetamol declaring it as illogical or irrational. 13 In the present study the fixed dose combination of diclofenac sodium and paracetamol is studied with respect to its analgesic, anti-inflammatory and antipyretic activities. The results were compared to individual drugs alone, the dose ratio selected was 1:10 for diclofenac, and paracetamol, the same as found in market preparations. Analgesic activity was studied by two methods viz tailclip method and writhing test. Tail clip method confirmed the presence of analgesia and also gave an idea about the duration of analgesic effect, the writhing test depicted the percentage protection showed by the drug against painful stimulus i.e. intensity of analgesia.
Acetic acid writhing method has advantage that the test takes less time, effect is of short duration, rapid in onset and exposure of animals to discomfort is curtailed. Its disadvantages lie in the fact that anti-nociceptive effect can't be easily distinguished from anti-inflammatory effect. The test produces false positives. 14 In the tail clip method diclofenac sodium 1mg/kg produced analgesia or shorter duration in comparison to the combination of 1mg/kg + 10 mg/kg of diclofenac sodium and paracetamol respectively and the difference was statistically significant (p<0.05). Diclofenac sodium in a higher dose of 2mg/kg when compared to the combination of 2mg/kg of diclofenac and 20mg/kg of paracetamol the difference in the duration of analgesia was not statistically significant (p>0.05).
In the writhing test, diclofenac 1mg/kg was superior to the combination of (1mg/kg and 10mg/kg) of diclofenac and paracetamol (where percentage inhibition or wriths were concerned) and the difference was statistically significant (p<0.05). in comparison with diclofenac 2mg/kg, the combination (2mg/kg + 20 mg/kg) showed less inhibition of writhing but the difference was not statistically significant (p>0.05).
In both the methods, paracetamol was an inferior analgesic as compared to the combination. In tail clip method, the duration of analgesia was less as compared to the combination and the difference was highly significant (p<0.001). In writhing method as compared to the combination and the difference was statistically significant (p<0.01).
The antinociceptive effect of diclofenac involves a central nervous component which may be elicited from several defined areas in the CNS. Part of the antinociceptive effect seems to be mediated by descending inhibitory opioid, serotonin and/or other neurotransmitter systems interfering with visceral pain impulse traffic at the spinal level. While NSAIDs and paracetamol interfere with nociception associated with spinal NMDA receptor activation. This effect involves an inhibitory action on spinal nitric oxide (NO) mechanisms. Possibly, the supraspinal antinociceptive effect of NSAIDs may be explained by an analogous action. 15 Anti-inflammatory activity was evaluated by carrageenan induced rat paw edema. Carrageenan is preferred to several other inflammatory agents because the edema produced is less influenced by non-specific factors such as vasodilatation, ganglion blockade or diuresis.
Diclofenac sodium 1mg/kg and 2mg/kg when compared to the combination of (1mg/kg + 10 mg/kg) and (2mg/kg +20 mg/kg) of diclofenac and paracetamol respectively, showed no significant difference in reduction in paw edema (p>0.05). This signified that the fixed dose combination is not superior to diclofenac sodium as far as anti-inflammatory effect is concerned.
Paracetamol 10mg/kg and 20mg/kg did show significant anti-inflammatory effect as compared to control (p<0.01) but in comparison to the combination, paracetamol was a weaker anti-inflammatory at both the losses and the difference was also statistically significant (p<0.01). This weaker anti-inflammatory effect is also seen in previous two studies. 16, 17 Anti-pyretic activity was evaluated by injecting bacterial pyrogen (TAB vaccine) in rats. The method was selected because the mechanism of fever which develops post TAB vaccine resembles the development of fever in man. 18 Also the fever does not show variation of more than 0.1 0 F over a 4hours study period.
As an antipyretic, paracetamol (20mg/kg) was a superior anti-pyretic drug was compared to both diclofenac sodium (2mg/kg) and the combination of (2mg/kg+20mg/kg) of diclofenac and paracetamol respectively. Paracetamol had a quicker onset of action, peak antipyresis observed at hrs. and temperature almost touched the baseline normal temperature. Diclofenac sodium (2mg/kg) did lower the temperature significantly; peak antipyresis at 4 hrs, but the temperature did not touch the baseline normal temperature. The combination also showed significant antipyresis but it was inferior to paracetamol and the difference was highly significant (p<0.001) at 4hours. Similarly, the combination was inferior to diclofenac (2mg/kg) and the difference was statistically significant (p<0.01) at 4 hours.
In all the above activities there is no evidence that the combination of diclofenac sodium and paracetamol in a fixed dose ratio is superior to individual drug diclofenac in analgesia, inflammation and to paracetamol where anti-pyresis was concerned.
Since the two drugs, have a common mechanism action (COX inhibition), share the same t1/2 (1-3hrs), volume of distribution (0.9-0.12l/kg), metabolic characteristics (glucuronide and sulphate conjugation) and identical elimination, some pharmacokinetic interactions may be expected which decrease the optimal effect of each drug. 19 The results of the present study support the same. Thus the fixed dose combination of diclofenac with paracetamol is irrational as far as therapeutic efficacy is concerned. Moreover, the same identical characteristics could lead to additive side effects in the form of gastric toxicity and analgesic nephropathy. 20, 21 However the results of this study carried out in experimental animals cannot be extrapolated to man, only the clinical studies in form of comparative clinical trial can validate these results. For example comparisons in post-operative pain or post-episiotomy pain for analgesia, in patients of rheumatoid arthritis for anti-inflammatory effects and so on. Present study can only indicate the lack of superiority diclofenac paracetamol combination over the two drugs individually in experimental models of pain, inflammation and pyrexia.
Few systemic reviews found that the concurrent use of paracetamol and NSAIDs was superior to paracetamol alone. However, no superior analgesic effect of the combination compared with the NSAID alone was found. 22, 23 Paracetamol-diclofenac appears to be best combination a similar finding to the work of Zezi and Abdulkadir where they also evaluated analgesic and anti-inflammatory efficacy using rat writhing test and hind limb paw edema model.
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CONCLUSION
There are many combinations of analgesics anti-pyretic drugs available in the market for treatment of various musculoskeletal disorders and pain relief. The fixed dose combination of diclofenac and paracetamol marketed exclusively in India is one such combination, a scientific study to establish rationality and justification of such combination was needed.
The three major therapeutic activities viz. analgesic, antiinflammatory and antipyretic were studied to compare the combination with individual drugs.
The combination was either equal or inferior but not superior in all the three activities studied as compared to the individual drugs. Diclofenac sodium was superior to the combination where analgesia was concerned; it was equal to combination in inflammation. Further paracetamol was a superior antipyretic as compared to both diclofenac sodium and the combination.
In view of many similarities, which exist in mechanism of action, distribution and elimination characteristics of these two drugs, the combination is not likely to be theoretically superior.
The combination could possibly lead to addition of toxic effects including severe gastric erosions, ulcerations and bleeding. Analgesic nephropathy well documented to be caused by analgesic-antipyretic combinations cannot be overlooked.
NSAIDs could be combined with opioids in pain relief to achieve synergistic effect. NSAIDs could be coadministered with paracetamol on "as and when required basis" but not as a fixed dose combination.
Prescribing fixed dose combination of NSAIDs limit flexibility of dosing and individualization of drug therapy.
Lastly, these experimental observations need to be validated by controlled clinical studies.
